China introduces rare disease drug market exclusivity to boost innovation
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
Beijing is rewiring its drug market rulebook to boost biotech innovation. What happened: On January 16, the State Council released updated regulations implementing the Drug Administration Law.
The revised regs will replace the current framework on May 15.
The shift: The revised rules lean hard int...